TSHA
NASDAQ · Biotechnology
Taysha Gene Therapies Inc
$4.33
+0.24 (+5.87%)
Open$4.16
Previous Close$4.09
Day High$4.45
Day Low$4.14
52W High$7.30
52W Low$3.46
Volume—
Avg Volume2.87M
Market Cap1.42B
P/E Ratio—
EPS$-0.41
SectorBiotechnology
Analyst Ratings
Strong Buy
19 analysts
Price Target
+1,305.5% upside
Current
$4.33
$4.33
Target
$60.86
$60.86
$45.99
$60.86 avg
$68.15
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.94M | 6.31M | 242.81M |
| Net Income | -110,694,506 | -63,241,957 | 41.01M |
| Profit Margin | -1,115.3% | -1,059.5% | 16.9% |
| EBITDA | -111,051,690 | -66,970,802 | 60.77M |
| Free Cash Flow | — | — | 46.40M |
| Rev Growth | +57.5% | +57.5% | -6.9% |
| Debt/Equity | 0.20 | 0.20 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $293.30 | +0.68% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $463.45 | +0.66% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $169.25 | +1.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $549.39 | +0.42% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $922.99 | +2.06% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.52 | +0.37% | 7.7 | 20.98B |